InvivoSciences, founded in 2001, is a precision medicine company specializing in patient-derived 3D micro-tissue platforms for drug development, particularly in cardiovascular diseases. Their technology integrates cell and tissue automation, phenotyping assays, and AI to enhance drug safety and efficacy assessments. They operate within the biotechnology industry.